Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer-Reference-Cited by-同舟云学术

Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer

Published:2019-08-31 Issue:6 Volume:22 Page:870-877
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Kirwan C. C.^ORCID,Descamps T.^ORCID,Castle J.^ORCID

Funder

The Bupa Foundation

Academy of Medical Sciences

University Hospital of South Manchester Research Endowment Fund

National Institute of Health Research Clinician Scientist Award

Cancer Research UK Manchester Centre Award

Manchester Experimental Cancer Medicine Centre

NIHR Manchester Biomedical Research Centre

University of Manchester

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-019-02197-6.pdf

Reference45 articles.

1. Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer—a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404–13 (PubMed PMID: 23146958).

2. Cronin-Fenton DP, Sondergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. Br J Cancer. 2010;103(7):947–53 (PubMed PMID: 20842120, Pubmed Central PMCID: 2965880).

3. Morgan MA, Iyengar TD, Napiorkowski BE, Rubin SC, Mikuta JJ. The clinical course of deep vein thrombosis in patients with gynecologic cancer. Gynecol Oncol. 2002;84(1):67–71 (PubMed PMID: 11748979).

4. Weiss RB, Tormey DC, Holland JF, Weinberg VE. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep. 1981;65(7–8):677–9 (PubMed PMID: 7248984).

5. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78(5):285–91 (PubMed PMID: 10499070).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil extracellular traps enhance procoagulant activity and predict poor prognosis in patients with metastatic breast cancer;2024-09-02

2. Thromboelastogram and coagulation function index: relevance for female breast cancer;Frontiers in Oncology;2024-07-17

3. Haemostatic Proteins as Markers of Disease Progression and Prognosis in Breast Cancer;2024-07-12

4. Inhibitory effect of recombinant tyrosine‑sulfated madanin‑1, a thrombin inhibitor, on the behavior of MDA‑MB‑231 and SKOV3 cells in vitro;Molecular Medicine Reports;2024-05-08

5. Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma;Hämostaseologie;2024-04-18